Global Inflammatory Bowel Disease Market Size | COVID-19 Impact Analysis | Forecast to 2025

Global Inflammatory Bowel Disease market is estimated to reach $23.9 billion in 2027, by growing at a CAGR of 4.5% during the forecast period (2021-2027). Increasing public and private investment in healthcare infrastructure is further contributing to the growth of the market. The players in the market are receiving funds for the development of IBD therapies, that is contributing to strengthening the portfolio of the market players, hence, surging the growth of the global IBD market. For instance, BiomX is one of the players that is focused on the development of customized phage therapies that target bacteria in chronic diseases such as IBD. The rise in the number of IBD such as Crohn’s disease and ulcerative colitis is augmenting the growth of the global IBD market. The increasing prevalence of IBD results in the need for research for the prevention of IBD and innovations in healthcare systems to manage this complex and costly disease.

To Request a Sample of our Report on Global Inflammatory Bowel Disease Market: https://www.omrglobal.com/request-sample/ibd-inflammatory-bowel-disease-therapeutics-market

Increasing funding for R&D of new products to promote the growth of the market over the forecast period

Numerous organizations across the globe are working so as to promote the R&D of new treatment alternatives for IBD across the globe. In line with this, in 2018, Crohn’s & Colitis Foundation has received a $3.3 million grant from the Leona M. and Harry B. Helmsley Charitable Trust so as to support the IBD care program initiated by the company. Moreover, in 2018, Patient-Centered Outcomes Research Institute (PCORI) funded $2.4 million to Crohn’s & Colitis Foundation; this was done so as to study the effect of small molecular therapies in IBD.
Scope of the Global Inflammatory Bowel Disease Market

Market Coverage
• Market number available - 2021-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- By Disease type and Treatment Type
• Regions Covered- North America (US and Canada), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and Rest of World (Middle East and Africa, Latin America)
• Competitive Landscape- Abbott Laboratories, AbbVie Inc., Allergan, PLC Celgene Corp., Eli Lilly and Co., Johnson & Johnson Services Inc., Pfizer Inc.
Recent Strategic Initiatives in the Global Inflammatory Bowel Disease Market
• In January 2019 Takeda completes acquisition of shire and becoming a global, Value-based, R&D driven biopharmaceutical leader. In January 2019, Takeda announces multiple cell therapy collaborations to advance the company’s novel immuno-oncology portfolio. Further, in December 2018 GARDP, Eisai and Takeda announce a partnership in the search for new antibiotics.
• In May 2018, Allergan PLC launched two IBD clinical research programs for brazikumab, a drug being studied for IBD. Moreover, the company is focussed on focused on R&D in four core areas that are medical aesthetics, eye care, central nervous system, and gastroenterology.

(Get 15% Discount on Buying this Report)
A full Report of Global Inflammatory Bowel Disease Market is Available at: https://www.omrglobal.com/industry-reports/ibd-inflammatory-bowel-disease-therapeutics-market

Global Inflammatory Bowel Disease Market-Segmentation

By Disease Type

• Ulcerative Colitis
• Crohn’s Disease

By Treatment Type

• Surgery
• Anti- Inflammatory Drug Administration
• Steroids
• Immunosuppressant

Global Inflammatory Bowel Disease Market– Segment by Country

North America

• US
• Canada

Europe

• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World

Company Profiles

• Abbott Laboratories
• AbbVie Inc.
• Allergan, PLC
• Celgene Corp.
• Eli Lilly and Co.
• Johnson & Johnson Services Inc.
• Pfizer Inc.
• Laboratory Corporation of America Holdings
• Mercator Pharmaceutical Solutions
• Pharmacosmos A/S
• RPG Life Sciences Ltd.
• Sanofi S.A.
• Takeda pharmaceutical Co., Ltd.
• UCB, Inc.
• Vifor Pharma Group

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/ibd-inflammatory-bowel-disease-therapeutics-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.